Cutaneous malignant melanoma

Deborah L. Cummins, Jordan M. Cummins, Hardin Pantle, Michael A. Silverman, Aimee L. Leonard, Arjun Chanmugam

Research output: Contribution to journalReview articlepeer-review

Abstract

Skin cancer has become the most common neoplasm in the United States. With early diagnosis and appropriate management, most skin cancers have an overall 5-year survival rate of 95%. Cutaneous malignant melanoma (CMM), however, has a significantly higher morbidity and mortality, resulting in 65% of all skin cancer deaths. Although the long-term survival rate for patients with metastatic melanoma is only 5%, early detection of CMM carries an excellent prognosis, with surgical excision often being curative. Primary care physicians can play a critical role in reducing morbidity and mortality from CMM by recognizing patients at risk, encouraging the adoption of risk-reducing behaviors, and becoming adept at identifying suspicious lesions.

Original languageEnglish (US)
Pages (from-to)500-507
Number of pages8
JournalMayo Clinic proceedings
Volume81
Issue number4
DOIs
StatePublished - Apr 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cutaneous malignant melanoma'. Together they form a unique fingerprint.

Cite this